Average Co-Inventor Count = 3.52
ph-index = 20
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Theravance Biopharma R&d Ip, LLC (78 from 262 patents)
2. Theravance, Inc. (46 from 386 patents)
3. Theravance Respiratory Company, LLC (12 from 12 patents)
136 patents:
1. 12351561 - Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
2. 12016835 - Neprilysin inhibitors
3. 11919888 - Neprilysin inhibitors
4. 11851443 - Neprilysin inhibitors
5. 11730720 - ALK5 inhibitors
6. 11718591 - Crystalline (2S,4R)-5-(5'-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof
7. 11673879 - Substituted pyrimidines and methods of use
8. 11642332 - (2R,4R)-5-(5'-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
9. 11634413 - Neprilysin inhibitors
10. 11590116 - Substituted pyridines and methods of use
11. 11547687 - Neprilysin inhibitors
12. 11261197 - Neprilysin inhibitors
13. 11230536 - Crystalline (2S,4R)-5-(5'-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
14. 11174219 - Neprilysin inhibitors
15. 11124502 - Neprilysin inhibitors